Research article · 6 Oct 2026
Conference abstractPublished 4 Dec 2017
Proliferative diabetic retinopathy - where are we now?
University Eye Clinic, Serbia; Private Eye Clinic Dzinic, Serbia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetic retinopathy is the fifth most common cause of blindness according to new researches. The number of people with moderate to severe visual loss due to DR is constantly growing. Treatment modalities are improving moving the shift from laser photocoagulation to intravitreal injections (anti-VEGF, corticosteroids). Advances in technology of modern vitreoretinal surgical systems, usage of vitreal dyes and smaller gauges (MIVS) allow us to intervene earlier during the disease. Our study presents the results of laser photocoagulation and anti-VEGF treatment approach as well as combined bimanual 4 port pars plana phaco-vitrectomy for advanced proliferative stages and epimacular membranes with or without ILM (inner limiting membrane) removal in the first surgery course. Fifty-three eyes (50 patients) were followed. Visual acuity (VA) ranges from light perception to 0.3. In 18 eyes silicon oil as a tamponade agent was used and removed after 3-6 months after the surgery and in 35 eyes tamponade agent was air. In 29 eyes ILM was peeled primary. In 24 eyes in which ILM was not peeled in the first surgery after 9-12 months epi-macular membrane with significant macular traction was observed in 7 (29.2%) eyes in which additional surgery with ILM peeling was performed. Mean VA at the end of the follow-up period was 0.3 (0.03-0.6) According to our results combined phaco-vitrectomy procedure presents the treatment of choice for patients with severe visual loss, vitreous hemorrhage’s combined with epimacular membrane and retinal proliferations. Primary peeling of internal limiting membrane ILM has beneficial effect in preventing reoccurrence of epi-macular membrane in diabetic patients. Further investigations are needed to confirm safety and potential damage to the nerve fibre layer to establish ILM peeling as primary procedure.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Vladislav Dzinic”

